Arthur Reshad Garan, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart-Assist Devices | 95 | 2024 | 1287 | 9.180 |
Why?
|
Shock, Cardiogenic | 55 | 2024 | 709 | 8.090 |
Why?
|
Extracorporeal Membrane Oxygenation | 38 | 2024 | 1462 | 4.720 |
Why?
|
Heart Failure | 92 | 2023 | 11669 | 4.190 |
Why?
|
Hemodynamics | 19 | 2024 | 4159 | 2.200 |
Why?
|
Heart Transplantation | 36 | 2023 | 3233 | 2.200 |
Why?
|
Myocardial Infarction | 22 | 2023 | 11460 | 1.940 |
Why?
|
Intra-Aortic Balloon Pumping | 8 | 2022 | 223 | 1.870 |
Why?
|
Heart Ventricles | 15 | 2022 | 3807 | 1.230 |
Why?
|
Defibrillators, Implantable | 5 | 2017 | 1490 | 1.150 |
Why?
|
Hospital Mortality | 32 | 2024 | 5294 | 1.030 |
Why?
|
Registries | 20 | 2024 | 8224 | 0.960 |
Why?
|
Ventricular Fibrillation | 4 | 2019 | 537 | 0.950 |
Why?
|
Ventricular Function, Left | 18 | 2023 | 3879 | 0.900 |
Why?
|
Cardiac Output | 2 | 2019 | 831 | 0.840 |
Why?
|
Tachycardia, Ventricular | 6 | 2020 | 1304 | 0.820 |
Why?
|
Retrospective Studies | 88 | 2024 | 80636 | 0.690 |
Why?
|
Primary Graft Dysfunction | 5 | 2019 | 111 | 0.680 |
Why?
|
Waiting Lists | 8 | 2020 | 765 | 0.620 |
Why?
|
Ventricular Function, Right | 8 | 2021 | 617 | 0.620 |
Why?
|
Prosthesis Implantation | 6 | 2020 | 592 | 0.590 |
Why?
|
Thrombosis | 12 | 2021 | 2942 | 0.550 |
Why?
|
Catheterization, Central Venous | 1 | 2020 | 527 | 0.510 |
Why?
|
Myocarditis | 1 | 2023 | 788 | 0.500 |
Why?
|
Hospices | 1 | 2018 | 245 | 0.500 |
Why?
|
Middle Aged | 101 | 2024 | 220895 | 0.490 |
Why?
|
Treatment Outcome | 52 | 2024 | 64680 | 0.490 |
Why?
|
Survival Rate | 22 | 2024 | 12725 | 0.470 |
Why?
|
Male | 113 | 2024 | 360804 | 0.450 |
Why?
|
Humans | 153 | 2024 | 761504 | 0.440 |
Why?
|
Ventricular Dysfunction, Right | 5 | 2021 | 628 | 0.440 |
Why?
|
Propensity Score | 3 | 2019 | 1913 | 0.430 |
Why?
|
Ventricular Dysfunction, Left | 7 | 2018 | 2118 | 0.430 |
Why?
|
New York | 7 | 2017 | 874 | 0.390 |
Why?
|
Aged | 67 | 2024 | 169289 | 0.390 |
Why?
|
Female | 103 | 2024 | 392644 | 0.380 |
Why?
|
Vascular Resistance | 2 | 2015 | 930 | 0.370 |
Why?
|
Disease Management | 2 | 2020 | 2508 | 0.350 |
Why?
|
Tricuspid Valve | 3 | 2018 | 410 | 0.350 |
Why?
|
Catheter Ablation | 4 | 2020 | 2751 | 0.340 |
Why?
|
Time Factors | 24 | 2020 | 39967 | 0.340 |
Why?
|
Prosthesis Design | 9 | 2024 | 2115 | 0.340 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2578 | 0.320 |
Why?
|
Assisted Circulation | 2 | 2019 | 100 | 0.300 |
Why?
|
Heart Arrest | 3 | 2024 | 1514 | 0.300 |
Why?
|
Pulmonary Artery | 4 | 2023 | 1927 | 0.290 |
Why?
|
Shock | 2 | 2022 | 314 | 0.290 |
Why?
|
Cardiopulmonary Resuscitation | 4 | 2024 | 992 | 0.260 |
Why?
|
Risk Factors | 32 | 2024 | 74206 | 0.260 |
Why?
|
Follow-Up Studies | 16 | 2020 | 39106 | 0.260 |
Why?
|
Streptomycin | 1 | 2005 | 69 | 0.250 |
Why?
|
Primary Prevention | 1 | 2013 | 1186 | 0.250 |
Why?
|
Postoperative Complications | 11 | 2020 | 15631 | 0.250 |
Why?
|
Creatinine | 2 | 2022 | 1899 | 0.250 |
Why?
|
Heart Septal Defects, Ventricular | 2 | 2019 | 477 | 0.240 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2005 | 189 | 0.240 |
Why?
|
Stroke Volume | 5 | 2023 | 5496 | 0.240 |
Why?
|
Tricuspid Valve Insufficiency | 3 | 2018 | 353 | 0.240 |
Why?
|
Lactates | 2 | 2023 | 405 | 0.240 |
Why?
|
Adult | 48 | 2023 | 221177 | 0.230 |
Why?
|
Incidence | 15 | 2022 | 21353 | 0.230 |
Why?
|
Antiporters | 1 | 2005 | 278 | 0.220 |
Why?
|
Heart Injuries | 1 | 2005 | 206 | 0.210 |
Why?
|
Atrial Fibrillation | 4 | 2022 | 5127 | 0.210 |
Why?
|
Thoracic Injuries | 1 | 2005 | 288 | 0.200 |
Why?
|
Glomerular Filtration Rate | 3 | 2020 | 2176 | 0.190 |
Why?
|
Catheters | 2 | 2023 | 427 | 0.190 |
Why?
|
Prosthesis-Related Infections | 2 | 2018 | 488 | 0.190 |
Why?
|
Reoperation | 4 | 2019 | 4303 | 0.190 |
Why?
|
Recovery of Function | 7 | 2019 | 2979 | 0.180 |
Why?
|
Cryosurgery | 1 | 2006 | 474 | 0.180 |
Why?
|
Sternotomy | 2 | 2018 | 128 | 0.180 |
Why?
|
Cardiac Resynchronization Therapy | 2 | 2017 | 555 | 0.180 |
Why?
|
Pulmonary Veins | 1 | 2006 | 743 | 0.170 |
Why?
|
New York City | 6 | 2019 | 731 | 0.170 |
Why?
|
Heart-Lung Transplantation | 1 | 2020 | 87 | 0.170 |
Why?
|
Palliative Care | 4 | 2019 | 3598 | 0.170 |
Why?
|
Cause of Death | 3 | 2019 | 3683 | 0.170 |
Why?
|
Axillary Artery | 1 | 2019 | 47 | 0.160 |
Why?
|
Advanced Cardiac Life Support | 1 | 2019 | 78 | 0.160 |
Why?
|
Endotoxemia | 1 | 2020 | 196 | 0.160 |
Why?
|
Cystatin C | 1 | 2020 | 269 | 0.150 |
Why?
|
Blood Group Antigens | 1 | 2020 | 184 | 0.150 |
Why?
|
Oxygenators | 1 | 2018 | 36 | 0.150 |
Why?
|
Erythrocyte Indices | 1 | 2019 | 144 | 0.150 |
Why?
|
Echocardiography | 5 | 2020 | 4989 | 0.150 |
Why?
|
Hemolysis | 2 | 2019 | 415 | 0.150 |
Why?
|
Cardiac Imaging Techniques | 1 | 2020 | 267 | 0.150 |
Why?
|
Prognosis | 10 | 2022 | 29625 | 0.150 |
Why?
|
Adenosine Monophosphate | 1 | 2019 | 231 | 0.150 |
Why?
|
Graft Rejection | 2 | 2018 | 4445 | 0.150 |
Why?
|
Cardiac Surgical Procedures | 3 | 2019 | 3627 | 0.150 |
Why?
|
Oxygenators, Membrane | 1 | 2017 | 56 | 0.150 |
Why?
|
Lymphocele | 1 | 2017 | 18 | 0.150 |
Why?
|
Exercise Tolerance | 2 | 2013 | 836 | 0.150 |
Why?
|
Risk Assessment | 10 | 2021 | 23995 | 0.140 |
Why?
|
Out-of-Hospital Cardiac Arrest | 1 | 2021 | 339 | 0.140 |
Why?
|
Gastrointestinal Hemorrhage | 3 | 2021 | 1116 | 0.140 |
Why?
|
Decompression, Surgical | 2 | 2019 | 607 | 0.140 |
Why?
|
Blood Pressure Determination | 2 | 2018 | 633 | 0.140 |
Why?
|
International Normalized Ratio | 2 | 2016 | 382 | 0.140 |
Why?
|
Ultrasonography, Doppler | 1 | 2019 | 462 | 0.140 |
Why?
|
Death, Sudden, Cardiac | 1 | 2005 | 1555 | 0.140 |
Why?
|
Kaplan-Meier Estimate | 8 | 2021 | 6484 | 0.140 |
Why?
|
United States | 18 | 2024 | 72334 | 0.140 |
Why?
|
Hypertension, Pulmonary | 2 | 2019 | 1578 | 0.140 |
Why?
|
Glucosides | 1 | 2021 | 512 | 0.140 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15500 | 0.140 |
Why?
|
Tacrolimus | 1 | 2020 | 733 | 0.140 |
Why?
|
L-Lactate Dehydrogenase | 2 | 2016 | 411 | 0.130 |
Why?
|
Hemorrhage | 4 | 2021 | 3424 | 0.130 |
Why?
|
Device Removal | 2 | 2018 | 630 | 0.130 |
Why?
|
Survival Analysis | 5 | 2019 | 10090 | 0.130 |
Why?
|
Pulsatile Flow | 1 | 2017 | 321 | 0.130 |
Why?
|
Cardiotonic Agents | 1 | 2019 | 539 | 0.130 |
Why?
|
ABO Blood-Group System | 1 | 2018 | 380 | 0.130 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2017 | 445 | 0.130 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 7390 | 0.130 |
Why?
|
Propanolamines | 2 | 2013 | 163 | 0.130 |
Why?
|
Amiodarone | 1 | 2017 | 217 | 0.130 |
Why?
|
Catheterization, Peripheral | 1 | 2019 | 343 | 0.130 |
Why?
|
Ischemia | 1 | 2024 | 1882 | 0.130 |
Why?
|
Vasoconstrictor Agents | 1 | 2019 | 654 | 0.130 |
Why?
|
Social Class | 3 | 2023 | 2004 | 0.120 |
Why?
|
Cardiac Valve Annuloplasty | 1 | 2015 | 51 | 0.120 |
Why?
|
Prothrombin Time | 1 | 2015 | 117 | 0.120 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2017 | 244 | 0.120 |
Why?
|
Acute Disease | 3 | 2024 | 7237 | 0.120 |
Why?
|
Fatal Outcome | 1 | 2019 | 1834 | 0.120 |
Why?
|
Respiratory Insufficiency | 1 | 2023 | 1230 | 0.120 |
Why?
|
Carbazoles | 2 | 2013 | 220 | 0.120 |
Why?
|
Stroke | 5 | 2021 | 9757 | 0.120 |
Why?
|
Cardiac Resynchronization Therapy Devices | 1 | 2015 | 122 | 0.120 |
Why?
|
Natural Language Processing | 1 | 2023 | 1162 | 0.120 |
Why?
|
Benzhydryl Compounds | 1 | 2021 | 916 | 0.120 |
Why?
|
Renal Replacement Therapy | 1 | 2016 | 282 | 0.120 |
Why?
|
Aortic Valve Insufficiency | 1 | 2018 | 576 | 0.110 |
Why?
|
Anticoagulants | 4 | 2017 | 4812 | 0.110 |
Why?
|
Proteinuria | 1 | 2016 | 607 | 0.110 |
Why?
|
Postoperative Care | 2 | 2017 | 1468 | 0.110 |
Why?
|
Papillary Muscles | 1 | 2014 | 192 | 0.110 |
Why?
|
Lisinopril | 1 | 2013 | 61 | 0.110 |
Why?
|
Mitral Valve Insufficiency | 1 | 2022 | 1400 | 0.100 |
Why?
|
Immunocompromised Host | 1 | 2018 | 856 | 0.100 |
Why?
|
Milrinone | 1 | 2013 | 86 | 0.100 |
Why?
|
Cohort Studies | 10 | 2021 | 41487 | 0.100 |
Why?
|
Academic Medical Centers | 2 | 2020 | 2759 | 0.100 |
Why?
|
Aortic Diseases | 1 | 2018 | 735 | 0.100 |
Why?
|
von Willebrand Diseases | 1 | 2014 | 132 | 0.100 |
Why?
|
Tissue Donors | 2 | 2021 | 2331 | 0.100 |
Why?
|
Prospective Studies | 8 | 2020 | 54425 | 0.100 |
Why?
|
Severity of Illness Index | 7 | 2019 | 15842 | 0.100 |
Why?
|
Perioperative Care | 1 | 2019 | 1033 | 0.100 |
Why?
|
Patient Readmission | 3 | 2020 | 3270 | 0.100 |
Why?
|
Cardiology | 2 | 2020 | 1656 | 0.090 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2017 | 874 | 0.090 |
Why?
|
Electrophysiology | 1 | 2014 | 1262 | 0.090 |
Why?
|
Physical Endurance | 1 | 2013 | 366 | 0.090 |
Why?
|
Warfarin | 2 | 2016 | 1483 | 0.090 |
Why?
|
Aorta, Thoracic | 1 | 2017 | 1096 | 0.090 |
Why?
|
Renal Insufficiency | 1 | 2016 | 809 | 0.090 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2017 | 1516 | 0.090 |
Why?
|
Hemoglobins | 1 | 2016 | 1525 | 0.090 |
Why?
|
Hematologic Diseases | 1 | 2014 | 496 | 0.090 |
Why?
|
Inflammation | 2 | 2020 | 10773 | 0.090 |
Why?
|
Heparin | 1 | 2017 | 1634 | 0.090 |
Why?
|
Tissue and Organ Procurement | 1 | 2018 | 961 | 0.090 |
Why?
|
Self Care | 1 | 2015 | 796 | 0.090 |
Why?
|
Blood Pressure | 3 | 2017 | 8481 | 0.080 |
Why?
|
Thrombocytopenia | 1 | 2017 | 1181 | 0.080 |
Why?
|
Catheterization | 2 | 2023 | 1428 | 0.080 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2016 | 1725 | 0.080 |
Why?
|
Medicare | 4 | 2022 | 6770 | 0.080 |
Why?
|
Oxidative Stress | 1 | 2020 | 3113 | 0.080 |
Why?
|
Patient Selection | 5 | 2020 | 4244 | 0.080 |
Why?
|
Heart Conduction System | 1 | 2014 | 1007 | 0.080 |
Why?
|
Cerebrovascular Circulation | 1 | 2019 | 2727 | 0.080 |
Why?
|
Pneumonia | 1 | 2020 | 2143 | 0.080 |
Why?
|
Cardiomyopathies | 1 | 2020 | 1964 | 0.080 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2014 | 829 | 0.080 |
Why?
|
Aortic Valve | 1 | 2018 | 1955 | 0.080 |
Why?
|
Obesity | 3 | 2020 | 12947 | 0.080 |
Why?
|
Income | 1 | 2016 | 1877 | 0.070 |
Why?
|
Respiration, Artificial | 1 | 2019 | 2628 | 0.070 |
Why?
|
Ambulatory Care | 1 | 2018 | 2775 | 0.070 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2019 | 2751 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2020 | 4174 | 0.070 |
Why?
|
Hypertension | 2 | 2018 | 8540 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8529 | 0.070 |
Why?
|
Amyloidosis | 1 | 2014 | 817 | 0.070 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2012 | 1241 | 0.070 |
Why?
|
Point-of-Care Systems | 1 | 2015 | 1213 | 0.070 |
Why?
|
Thoracic Surgical Procedures | 2 | 2020 | 349 | 0.070 |
Why?
|
Terminal Care | 1 | 2018 | 1760 | 0.070 |
Why?
|
Intensive Care Units | 1 | 2019 | 3745 | 0.070 |
Why?
|
Electronic Health Records | 1 | 2023 | 4811 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2019 | 3600 | 0.060 |
Why?
|
Comorbidity | 5 | 2019 | 10508 | 0.060 |
Why?
|
Heart Rate | 2 | 2019 | 4195 | 0.060 |
Why?
|
Patient Discharge | 1 | 2018 | 3443 | 0.060 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2015 | 1553 | 0.060 |
Why?
|
Acute Kidney Injury | 1 | 2017 | 1924 | 0.060 |
Why?
|
Prevalence | 5 | 2024 | 15732 | 0.060 |
Why?
|
Age Factors | 2 | 2018 | 18395 | 0.060 |
Why?
|
Ventricular Pressure | 1 | 2005 | 210 | 0.060 |
Why?
|
Insurance, Health | 1 | 2016 | 2498 | 0.060 |
Why?
|
Primary Health Care | 1 | 2020 | 4686 | 0.060 |
Why?
|
Diabetes Mellitus | 2 | 2019 | 5840 | 0.060 |
Why?
|
Hospitalization | 1 | 2023 | 10723 | 0.060 |
Why?
|
Equipment Failure | 2 | 2016 | 578 | 0.050 |
Why?
|
Preoperative Period | 2 | 2016 | 551 | 0.050 |
Why?
|
Sheep | 1 | 2006 | 1440 | 0.050 |
Why?
|
Postoperative Period | 2 | 2020 | 1813 | 0.050 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3358 | 0.050 |
Why?
|
Aged, 80 and over | 5 | 2020 | 58976 | 0.050 |
Why?
|
Cost-Benefit Analysis | 3 | 2021 | 5492 | 0.050 |
Why?
|
Chronic Disease | 1 | 2018 | 9318 | 0.050 |
Why?
|
Transcription Factors | 1 | 2022 | 12128 | 0.050 |
Why?
|
Proportional Hazards Models | 4 | 2019 | 12463 | 0.050 |
Why?
|
Disease Progression | 4 | 2023 | 13506 | 0.050 |
Why?
|
Coronary Angiography | 2 | 2023 | 4471 | 0.050 |
Why?
|
Kidney | 1 | 2017 | 7048 | 0.050 |
Why?
|
Myocardium | 2 | 2015 | 4726 | 0.050 |
Why?
|
Liver | 1 | 2017 | 7529 | 0.050 |
Why?
|
Algorithms | 3 | 2019 | 14031 | 0.050 |
Why?
|
Translating | 1 | 2022 | 143 | 0.050 |
Why?
|
Heart Diseases | 1 | 2014 | 2781 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2017 | 9177 | 0.040 |
Why?
|
Random Allocation | 1 | 2005 | 2395 | 0.040 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2021 | 273 | 0.040 |
Why?
|
Heart | 1 | 2013 | 4404 | 0.040 |
Why?
|
Odds Ratio | 3 | 2018 | 9646 | 0.040 |
Why?
|
Blood Volume | 1 | 2021 | 547 | 0.040 |
Why?
|
Hospitals | 2 | 2023 | 3882 | 0.040 |
Why?
|
Denmark | 1 | 2021 | 771 | 0.040 |
Why?
|
Extremities | 1 | 2024 | 867 | 0.040 |
Why?
|
Communication Barriers | 1 | 2022 | 413 | 0.040 |
Why?
|
Equipment Design | 2 | 2017 | 3510 | 0.040 |
Why?
|
Wounds, Nonpenetrating | 1 | 2005 | 807 | 0.040 |
Why?
|
Blood Grouping and Crossmatching | 1 | 2018 | 100 | 0.040 |
Why?
|
Prosthesis Failure | 2 | 2014 | 1204 | 0.040 |
Why?
|
Databases, Factual | 3 | 2020 | 7967 | 0.040 |
Why?
|
Adolescent | 4 | 2023 | 88319 | 0.040 |
Why?
|
Markov Chains | 1 | 2021 | 966 | 0.040 |
Why?
|
Taiwan | 1 | 2019 | 521 | 0.040 |
Why?
|
Biopsy | 1 | 2009 | 6766 | 0.040 |
Why?
|
Early Diagnosis | 1 | 2022 | 1186 | 0.040 |
Why?
|
Electrocardiography | 2 | 2014 | 6377 | 0.040 |
Why?
|
Groin | 1 | 2017 | 106 | 0.040 |
Why?
|
Urofollitropin | 1 | 2016 | 2 | 0.040 |
Why?
|
Graft Survival | 2 | 2018 | 3819 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 10766 | 0.030 |
Why?
|
Oxygen Consumption | 2 | 2013 | 1866 | 0.030 |
Why?
|
Health Services Accessibility | 1 | 2014 | 5440 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2023 | 20098 | 0.030 |
Why?
|
Young Adult | 3 | 2018 | 59243 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2006 | 18252 | 0.030 |
Why?
|
Resuscitation Orders | 1 | 2018 | 270 | 0.030 |
Why?
|
Predictive Value of Tests | 3 | 2019 | 15266 | 0.030 |
Why?
|
Blood Flow Velocity | 1 | 2019 | 1371 | 0.030 |
Why?
|
Xiphoid Bone | 1 | 2014 | 10 | 0.030 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2016 | 352 | 0.030 |
Why?
|
Swine | 1 | 2005 | 5915 | 0.030 |
Why?
|
Recurrence | 2 | 2019 | 8465 | 0.030 |
Why?
|
Femoral Artery | 1 | 2019 | 826 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2021 | 1722 | 0.030 |
Why?
|
Urinalysis | 1 | 2016 | 368 | 0.030 |
Why?
|
Laboratories, Hospital | 1 | 2015 | 192 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2009 | 14605 | 0.030 |
Why?
|
Logistic Models | 2 | 2019 | 13255 | 0.030 |
Why?
|
Transaminases | 1 | 2013 | 198 | 0.030 |
Why?
|
Diffusion of Innovation | 1 | 2018 | 728 | 0.030 |
Why?
|
Bisoprolol | 1 | 2012 | 9 | 0.030 |
Why?
|
Cardiovascular Agents | 1 | 2019 | 840 | 0.030 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2017 | 774 | 0.030 |
Why?
|
Resuscitation | 1 | 2017 | 673 | 0.030 |
Why?
|
Language | 1 | 2022 | 1540 | 0.030 |
Why?
|
Metoprolol | 1 | 2012 | 90 | 0.020 |
Why?
|
Bilirubin | 1 | 2013 | 436 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2017 | 1440 | 0.020 |
Why?
|
Creatine | 1 | 2013 | 427 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 2019 | 1779 | 0.020 |
Why?
|
Cardiopulmonary Bypass | 1 | 2016 | 1092 | 0.020 |
Why?
|
Postoperative Hemorrhage | 1 | 2014 | 415 | 0.020 |
Why?
|
Cell Movement | 1 | 2022 | 5203 | 0.020 |
Why?
|
Critical Care | 1 | 2023 | 2696 | 0.020 |
Why?
|
Blood Coagulation | 1 | 2016 | 1154 | 0.020 |
Why?
|
Fluoroscopy | 1 | 2014 | 947 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3416 | 0.020 |
Why?
|
Pericardium | 1 | 2014 | 675 | 0.020 |
Why?
|
Norepinephrine | 1 | 2012 | 897 | 0.020 |
Why?
|
Endoscopy | 1 | 2019 | 1851 | 0.020 |
Why?
|
Remission Induction | 1 | 2015 | 2396 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2021 | 3826 | 0.020 |
Why?
|
Thromboembolism | 1 | 2016 | 995 | 0.020 |
Why?
|
Educational Status | 1 | 2016 | 2522 | 0.020 |
Why?
|
ROC Curve | 1 | 2016 | 3579 | 0.020 |
Why?
|
Canada | 1 | 2014 | 2122 | 0.020 |
Why?
|
Ventricular Remodeling | 1 | 2016 | 1267 | 0.020 |
Why?
|
HIV Infections | 1 | 2014 | 17351 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2017 | 6310 | 0.020 |
Why?
|
Walking | 1 | 2013 | 1198 | 0.020 |
Why?
|
Risk | 1 | 2018 | 9610 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2017 | 5247 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2016 | 4243 | 0.020 |
Why?
|
Respiration | 1 | 2012 | 1657 | 0.020 |
Why?
|
Linear Models | 1 | 2015 | 5871 | 0.020 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2243 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10552 | 0.020 |
Why?
|
Data Collection | 1 | 2014 | 3322 | 0.010 |
Why?
|
Exercise Test | 1 | 2012 | 2127 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2012 | 4853 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2012 | 6228 | 0.010 |
Why?
|
Animals | 2 | 2006 | 168459 | 0.010 |
Why?
|
Medicaid | 1 | 2016 | 2818 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12059 | 0.010 |
Why?
|
Body Mass Index | 1 | 2020 | 12953 | 0.010 |
Why?
|
Length of Stay | 1 | 2016 | 6425 | 0.010 |
Why?
|
Genotype | 1 | 2016 | 12990 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 26125 | 0.010 |
Why?
|
Models, Statistical | 1 | 2012 | 5079 | 0.010 |
Why?
|
Quality of Life | 1 | 2019 | 13367 | 0.010 |
Why?
|